In the Treatment of Tuberculosis, You Get What You Pay for…

This publication has 6 references indexed in Scilit:

• A Nested Case–Control Study on Treatment-related Risk Factors for Early Relapse of Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2004
• Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial
  The Lancet, 2002
• Controlled Trial of 2, 4, and 6 Months of Pyrazinamide in 6-Month, Three-Times-Weekly Regimens for Smear-positive Pulmonary Tuberculosis, Including an Assessment of a Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide: Results at 30 Months
  American Review of Respiratory Disease, 1991
• A Controlled Clinical Comparison of 6 and 8 Months of Antituberculosis Chemotherapy in the Treatment of Patients with Silicotuberculosis in Hong Kong
  American Review of Respiratory Disease, 1991
• A 62-Dose, 6-Month Therapy for Pulmonary and Extrapulmonary Tuberculosis
  Annals of Internal Medicine, 1990
• Suitability of rifampicin for intermittent administration in the treatment of tuberculosis
  Tubercle, 1970